Clinical trial
Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive…
NCT00182520 · McMaster University, Other · Completed
Key facts
| NCT number | NCT00182520 |
|---|---|
| Title | Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD) |
| Official title | A Study of Topiramate Augmentation in Serotonin Reuptake Inhibitor (SRI) -Refractory Obsessive Compulsive Disorder |
| Lead sponsor | McMaster University, Other |
| Collaborators | Janssen-Ortho Inc., Canada Industry Hamilton Health Sciences Corporation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Obsessive Compulsive Disorder |
| Intervention type | Drug |
| Interventions | Topiramate, placebo |
| Enrollment | 23 |
| Start date | Jan 1, 2002 |
| Primary completion | Jan 1, 2019 |
| Completion | Jan 1, 2019 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 1, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: